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Diabetes, Cardiovascular
Disease, and Ethnicity*
Prakash Deedwania, MD
Fresno, California
Diabetes mellitus (DM) and cardiovascular disease (CVD)
have become major public health challenges around the
world. Both DM and CVD are leading causes of death and
disability in developed nations. Recent data indicate that
with rapidly rising rates of obesity and metabolic syndrome
globally, both DM and CVD have become the leading
chronic disorders affecting populations across the world. Of
the estimated 16 million deaths resulting from CVD in
2001, the vast majority (13 million) occurred in low- and
middle-income countries (1). The alarming increases ob-
served in the rate of DM and CVD in developing nations
represent a major threat to human health and have become
serious public health concerns of enormous magnitude.
See page 1777
Although the prevalence of DM has increased globally,
there seem to be disproportionally higher rates of develop-
ment of DM in racial and ethnic minority populations (1,2).
For example, people of South Asian origin (both in their
native countries as well as migrant populations) have one of
the highest rates of developing DM, and India is now
labeled as the diabetes capital of the world, having in excess
of 50 million people with DM. Similarly, the rate of DM is
expected to increase by 150% in sub-Saharan Africa in the
next 10 to 15 years (1–3). This rapid explosion in the rates
of DM is likely to be associated with significant increases in
the rates of coronary heart disease (CHD) and strokes across
the world in people of various ethnic backgrounds. The
available data indicate that although the presence of DM is
associated with significant increase in the overall death rate,
its impact on CHD events and strokes and the related
morbidity and mortality indeed may differ based on ethnic-
ity (1–3). Therefore, it is critical to examine and evaluate the
impact of various racial and ethnic differences on the
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CV disease burden to understand better and to explore
opportunities to narrow down the existing health-related
racial, ethnic, and gender disparities.
The paper by Tillin et al. (4) in this issue of the Journal
ighlights the importance of these ethnic differences by
xamining the impact of DM and other metabolic risk
actors on incident CVD in people of 3 different ethnic
ackgrounds during a 20-year follow-up evaluation in the
ABRE (Southall and Brent Revisited) study. This was a
ri-ethnic community-based cohort study from northwest
ondon in which 4,196 middle-aged subjects (mean age: 52
ears) who were enrolled originally for assessment for DM
nd other cardiometabolic risk factors in the SABRE study
ere evaluated after a mean of 20 years for mortality and
ncident CVD by chart reviews and health care authority
ata, and survivors were invited for follow-up evaluation.
lthough most subjects were of European descent (n 
,049), there were 1,517 South Asians and 630 people of
frican Caribbean origin.
The main results of this study showed that there were
ignificant differences in the phenotypic patterns in the 3
thnic cohorts. As expected, there was higher prevalence
almost 3-fold) of DM in South Asians and African
aribbeans along with more central obesity and atherogenic
yslipidemia in South Asians than in the African Caribbean
ohort (4). Compared with Europeans, the incidence of
HD events was higher in South Asians, but lower in
frican Caribbean subjects. In contrast, both South Asians
nd African Caribbean cohorts experienced more stroke
vents compared with subjects of European descent. This
tudy does provide interesting data regarding the difference
n the prevalence of DM and other metabolic risk factors as
ell as the impact of these parameters on incident CVD (4).
owever, before further discussion of these differences and
he plausible explanation for the difference, it is important
o note that there are some inherent problems and limita-
ions in the study (4).
First, it should be noted that there were a disproportion-
te number of subjects with the 3 ethnicities. It is also
mportant to recognize that the data from South Asians
iving in Southall do not represent all South Asians, because
he primary population in Southall is of Punjabi and Sikh
escent, whereas South Asians as a whole are a heteroge-
eous group with varying dietary habits and lifestyles.
imilarly, the African Caribbean cohort in this study does
ot represent all people of African descent. Therefore, the
esults of this study may not be applicable to all South
sians and people of African descent. The authors contend
hat there was no sex and ethnicity interaction (4). How-
ver, this may not be an accurate assessment because of the
maller number of women, especially in the South Asian
ohort. A major limitation of the data in this study is that
he evaluation for DM and other metabolic risk factors was
nly made at the beginning of the study, and there is no
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ration, as well as new onset) in these parameters (which are
quite likely given the nature of these variables) during the
long follow-up period of 20 years. With a mean age of 52
years in the overall cohort, it is certain that there were
considerable change(s) in the risk profile during this long
period. Furthermore, some recent findings suggest that
changes do occur in these parameters over time because of
changing lifestyles, improving dietary patterns, as well as
healthcare interventions (5). The lack of information about
the changes in risk profile during the 20 years of follow-up
lead me to question the authors inference that differences in
CVD between ethnic groups remained even after adjust-
ment for conventional cardiometabolic risk factors. The
authors themselves contend in their conclusion that changes
in these parameters across the life course of subjects indeed
may be the key (4).
The lack of information regarding the treatment received
by the study subjects for important risk factors such as
diabetes, hypertension, and dyslipidemia also makes it
difficult to put these data in proper perspective. With the
well-known efficacy of statins in reducing CVD and stroke
rates especially in DM, it is likely that many subjects did
indeed receive such therapy, which certainly would alter the
natural history of CVD and the subsequent outcome.
Finally, it is also important to realize that because of the
limited number of events, many of which were soft events
(such as angina and coronary interventions), the study has
limited power and there is a possibility for spurious findings,
thereby limiting the usefulness of these findings for reliable
conclusions and clinical implication.
Despite these limitations, the study is important because
it is a moderately sized community study of 3 different
ethnic groups living in a similar environment and it does
provide reasonable comparison of the impact of DM and
other metabolic risk factors on incident CVD during a long
follow-up period (4). The findings of this study are impor-
tant because there is paucity of data comparing cardiometa-
bolic risk profiles in various ethnic groups and their rela-
tionship to incident CVD. The differences observed in the
phenotypic patterns and incident CVD and stroke rates in
the SABRE study are interesting. One of the main findings
was that compared with Europeans, both South Asians and
African Caribbeans had more DM and hypertension despite
lower body mass index. This may well be related to more
prevalent central obesity in South Asians and African
Caribbeans (6). It is now well recognized that visceral
adipose tissue (rather than subcutaneous fat) is a greater
harbinger of insulin resistance (6,7). Visceral adipose tissue
is considered by many to be an endocrine organ because of
its ability to release a variety of hormonal substances and
inflammatory mediators responsible for insulin resistance
and increased cardiovascular risk. The pathogenesis of DM
in South Asians and African Caribbeans also may be
different because there is evidence of more insulin resistance
in South Asians, whereas African Caribbeans may havebeta-cell dysfunction (7). It is conceivable that such a higher
prevalence of insulin resistance may well account for a
higher incidence of CHD events in South Asians when
compared with both European and African Caribbean
cohorts in this study. It is important to recognize that
insulin resistance is associated with atherogenic dyslipide-
mia and changes in balance between intrinsic prothrombotic
and thrombolytic milieu that also may account for differ-
ences in the impact of DM in various cohorts in this study.
The authors note that high-density lipoprotein and low-
density lipoprotein cholesterol levels did not account for the
protection from CHD in African Caribbeans. However,
without data about the functionality and particle character-
istics of these lipoproteins, it is difficult to evaluate their
role. It is known that South Asians have a heterogenic lipid
profile because of the predominance of small, dense low-
density lipoprotein cholesterol particles along with low
high-density lipoprotein cholesterol levels, whereas African
Caribbeans usually have a more favorable lipid profile,
which can account for difference in the rate of CHD events.
Future studies should evaluate these parameters and func-
tionality of lipoproteins to ascertain better the ethnic dif-
ferences in the incidence of CHD.
Although DM was predictive of an increased risk of
stroke in all ethnic groups, its effect was most profound in
African Caribbeans. The increased risk of stroke in African
Caribbeans should not be surprising given that the risk of
stroke is closely related to hypertension, which was signif-
icantly more prevalent in African Caribbeans than in either
Europeans or South Asians. The duration of hypertension
also is important, and although no data are given regarding
the duration of hypertension, it is quite likely that blood
pressure abnormalities were present for a longer period and
were more profound in those with DM. Also, the control
rates of hypertension have been reported generally to be
lower in African Caribbeans, and that also may have
contributed to the increased risk of stroke. It is known that
hypertension develops in many subjects in the prediabetic
phase, and often there is minimal to no physiologic noctur-
nal dip in blood pressure in presence of DM. Recent data
also show that the prevalence of hypertension is increasing
in South Asians as well (8). It therefore is likely that despite
relatively lower prevalence of hypertension in South Asians
at baseline, there was a significant increase in both preva-
lence of hypertension as well as systolic blood pressure levels
during the 20-year follow-up period secondary to advancing
age as well as development of new-onset DM, which would
indeed explain the high risk of stroke in South Asians as
well.
The difference in the rates of incident CVD and stroke in
various ethnic subgroups in the United Kingdom have been
reported previously nearly 20 years ago (1–3). The persis-
tence of these ethnic differences in the cardiovascular risk
factors and incident CVD during such a long period is quite
concerning because of the growing magnitude of problem.
There is an urgent need for more concerted efforts to
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cardiovascular risk factors, their control rates, and subse-
quent relationship with CVD in various ethnic cohorts.
Diabetes and CVD already have become the leading causes
of death and disability in minority populations and various
ethnic cohorts across the world, often affecting younger
people in many developing nations such as India (1,9,10).
There is an urgent need to devote adequate resources toward
research in these areas and to implement appropriate public
health measures to prevent the oncoming tsunami of
chronic, debilitating, and deadly disorders like diabetes and
cardiovascular disease around the world (9,10).
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